id	sid	tid	token	lemma	pos
cord-029882-kufs0fxe	1	1	key	key	JJ
cord-029882-kufs0fxe	2	1	:	:	:
cord-029882-kufs0fxe	2	2	cord-029882-kufs0fxe	cord-029882-kufs0fxe	NNS
cord-029882-kufs0fxe	2	3	authors	author	NNS
cord-029882-kufs0fxe	2	4	:	:	:
cord-029882-kufs0fxe	2	5	Malviya	Malviya	NNP
cord-029882-kufs0fxe	2	6	,	,	,
cord-029882-kufs0fxe	2	7	Amit	Amit	NNP
cord-029882-kufs0fxe	2	8	title	title	NN
cord-029882-kufs0fxe	2	9	:	:	:
cord-029882-kufs0fxe	3	1	The	the	DT
cord-029882-kufs0fxe	3	2	continued	continued	JJ
cord-029882-kufs0fxe	3	3	dilemma	dilemma	NN
cord-029882-kufs0fxe	3	4	about	about	IN
cord-029882-kufs0fxe	3	5	usage	usage	NN
cord-029882-kufs0fxe	3	6	of	of	IN
cord-029882-kufs0fxe	3	7	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-029882-kufs0fxe	3	8	:	:	:
cord-029882-kufs0fxe	3	9	Respite	respite	NN
cord-029882-kufs0fxe	3	10	is	be	VBZ
cord-029882-kufs0fxe	3	11	in	in	IN
cord-029882-kufs0fxe	3	12	randomized	randomized	JJ
cord-029882-kufs0fxe	3	13	control	control	NN
cord-029882-kufs0fxe	3	14	trials	trial	NNS
cord-029882-kufs0fxe	3	15	date	date	NN
cord-029882-kufs0fxe	3	16	:	:	:
cord-029882-kufs0fxe	3	17	2020	2020	CD
cord-029882-kufs0fxe	3	18	-	-	HYPH
cord-029882-kufs0fxe	3	19	07	07	CD
cord-029882-kufs0fxe	3	20	-	-	HYPH
cord-029882-kufs0fxe	3	21	29	29	CD
cord-029882-kufs0fxe	3	22	journal	journal	NN
cord-029882-kufs0fxe	3	23	:	:	:
cord-029882-kufs0fxe	4	1	Int	Int	NNP
cord-029882-kufs0fxe	4	2	J	J	NNP
cord-029882-kufs0fxe	4	3	Infect	infect	VB
cord-029882-kufs0fxe	4	4	Dis	Dis	NNP
cord-029882-kufs0fxe	4	5	DOI	doi	NN
cord-029882-kufs0fxe	4	6	:	:	:
cord-029882-kufs0fxe	5	1	10.1016	10.1016	CD
cord-029882-kufs0fxe	5	2	/	/	SYM
cord-029882-kufs0fxe	5	3	j.ijid.2020.07.054	j.ijid.2020.07.054	NN
cord-029882-kufs0fxe	5	4	sha	sha	NN
cord-029882-kufs0fxe	5	5	:	:	:
cord-029882-kufs0fxe	5	6	85b0f1dd0b056310a9905183f1f93b8de6dea0bf	85b0f1dd0b056310a9905183f1f93b8de6dea0bf	CD
cord-029882-kufs0fxe	5	7	doc_id	doc_id	CD
cord-029882-kufs0fxe	5	8	:	:	:
cord-029882-kufs0fxe	5	9	29882	29882	CD
cord-029882-kufs0fxe	5	10	cord_uid	cord_uid	NNS
cord-029882-kufs0fxe	5	11	:	:	:
cord-029882-kufs0fxe	6	1	kufs0fxe	kufs0fxe	NNP
cord-029882-kufs0fxe	6	2	nan	nan	NNP
cord-029882-kufs0fxe	6	3	is	be	VBZ
cord-029882-kufs0fxe	6	4	notable	notable	JJ
cord-029882-kufs0fxe	6	5	that	that	IN
cord-029882-kufs0fxe	6	6	in	in	IN
cord-029882-kufs0fxe	6	7	the	the	DT
cord-029882-kufs0fxe	6	8	present	present	JJ
cord-029882-kufs0fxe	6	9	study	study	NN
cord-029882-kufs0fxe	6	10	,	,	,
cord-029882-kufs0fxe	6	11	concomitant	concomitant	JJ
cord-029882-kufs0fxe	6	12	use	use	NN
cord-029882-kufs0fxe	6	13	of	of	IN
cord-029882-kufs0fxe	6	14	steroid	steroid	NN
cord-029882-kufs0fxe	6	15	in	in	IN
cord-029882-kufs0fxe	6	16	patients	patient	NNS
cord-029882-kufs0fxe	6	17	receiving	receive	VBG
cord-029882-kufs0fxe	6	18	hydroxychloroquine	hydroxychloroquine	NN
cord-029882-kufs0fxe	6	19	,	,	,
cord-029882-kufs0fxe	6	20	was	be	VBD
cord-029882-kufs0fxe	6	21	more	more	JJR
cord-029882-kufs0fxe	6	22	than	than	IN
cord-029882-kufs0fxe	6	23	non	non	JJ
cord-029882-kufs0fxe	6	24	-	-	JJ
cord-029882-kufs0fxe	6	25	treated	treated	JJ
cord-029882-kufs0fxe	6	26	group	group	NN
cord-029882-kufs0fxe	6	27	.	.	.
cord-029882-kufs0fxe	7	1	So	so	RB
cord-029882-kufs0fxe	7	2	,	,	,
cord-029882-kufs0fxe	7	3	in	in	IN
cord-029882-kufs0fxe	7	4	absence	absence	NN
cord-029882-kufs0fxe	7	5	of	of	IN
cord-029882-kufs0fxe	7	6	this	this	DT
cord-029882-kufs0fxe	7	7	critical	critical	JJ
cord-029882-kufs0fxe	7	8	information	information	NN
cord-029882-kufs0fxe	7	9	about	about	IN
cord-029882-kufs0fxe	7	10	the	the	DT
cord-029882-kufs0fxe	7	11	duration	duration	NN
cord-029882-kufs0fxe	7	12	between	between	IN
cord-029882-kufs0fxe	7	13	the	the	DT
cord-029882-kufs0fxe	7	14	onset	onset	NN
cord-029882-kufs0fxe	7	15	of	of	IN
cord-029882-kufs0fxe	7	16	symptoms	symptom	NNS
cord-029882-kufs0fxe	7	17	and	and	CC
cord-029882-kufs0fxe	7	18	administration	administration	NN
cord-029882-kufs0fxe	7	19	of	of	IN
cord-029882-kufs0fxe	7	20	first	first	JJ
cord-029882-kufs0fxe	7	21	dose	dose	NN
cord-029882-kufs0fxe	7	22	of	of	IN
cord-029882-kufs0fxe	7	23	HCQ	HCQ	NNP
cord-029882-kufs0fxe	7	24	,	,	,
cord-029882-kufs0fxe	7	25	it	-PRON-	PRP
cord-029882-kufs0fxe	7	26	seems	seem	VBZ
cord-029882-kufs0fxe	7	27	difficult	difficult	JJ
cord-029882-kufs0fxe	7	28	to	to	TO
cord-029882-kufs0fxe	7	29	interpret	interpret	VB
cord-029882-kufs0fxe	7	30	that	that	IN
cord-029882-kufs0fxe	7	31	the	the	DT
cord-029882-kufs0fxe	7	32	positive	positive	JJ
cord-029882-kufs0fxe	7	33	effects	effect	NNS
cord-029882-kufs0fxe	7	34	were	be	VBD
cord-029882-kufs0fxe	7	35	due	due	JJ
cord-029882-kufs0fxe	7	36	to	to	IN
cord-029882-kufs0fxe	7	37	HCQ	HCQ	NNP
cord-029882-kufs0fxe	7	38	or	or	CC
cord-029882-kufs0fxe	7	39	steroids	steroid	NNS
cord-029882-kufs0fxe	7	40	.	.	.
cord-029882-kufs0fxe	8	1	HCQ	HCQ	NNP
cord-029882-kufs0fxe	8	2	is	be	VBZ
cord-029882-kufs0fxe	8	3	touted	tout	VBN
cord-029882-kufs0fxe	8	4	for	for	IN
cord-029882-kufs0fxe	8	5	treatment	treatment	NN
cord-029882-kufs0fxe	8	6	of	of	IN
cord-029882-kufs0fxe	8	7	Covid	Covid	NNP
cord-029882-kufs0fxe	8	8	19	19	CD
cord-029882-kufs0fxe	8	9	primarily	primarily	RB
cord-029882-kufs0fxe	8	10	based	base	VBN
cord-029882-kufs0fxe	8	11	on	on	IN
cord-029882-kufs0fxe	8	12	its	-PRON-	PRP$
cord-029882-kufs0fxe	8	13	anti	anti	JJ
cord-029882-kufs0fxe	8	14	-	-	JJ
cord-029882-kufs0fxe	8	15	viral	viral	JJ
cord-029882-kufs0fxe	8	16	properties	property	NNS
cord-029882-kufs0fxe	8	17	,	,	,
cord-029882-kufs0fxe	8	18	thus	thus	RB
cord-029882-kufs0fxe	8	19	the	the	DT
cord-029882-kufs0fxe	8	20	timing	timing	NN
cord-029882-kufs0fxe	8	21	of	of	IN
cord-029882-kufs0fxe	8	22	administration	administration	NN
cord-029882-kufs0fxe	8	23	becomes	become	VBZ
cord-029882-kufs0fxe	8	24	very	very	RB
cord-029882-kufs0fxe	8	25	important	important	JJ
cord-029882-kufs0fxe	8	26	for	for	IN
cord-029882-kufs0fxe	8	27	a	a	DT
cord-029882-kufs0fxe	8	28	meaning	meaning	NN
cord-029882-kufs0fxe	8	29	full	full	JJ
cord-029882-kufs0fxe	8	30	assessment	assessment	NN
cord-029882-kufs0fxe	8	31	of	of	IN
cord-029882-kufs0fxe	8	32	study	study	NN
cord-029882-kufs0fxe	8	33	results	result	NNS
cord-029882-kufs0fxe	8	34	.	.	.
cord-029882-kufs0fxe	9	1	Secondly	secondly	RB
cord-029882-kufs0fxe	9	2	,	,	,
cord-029882-kufs0fxe	9	3	HCQ	HCQ	NNP
cord-029882-kufs0fxe	9	4	concentrates	concentrate	VBZ
cord-029882-kufs0fxe	9	5	in	in	IN
cord-029882-kufs0fxe	9	6	lungs	lung	NNS
cord-029882-kufs0fxe	9	7	after	after	IN
cord-029882-kufs0fxe	9	8	initial	initial	JJ
cord-029882-kufs0fxe	9	9	doses	dose	NNS
cord-029882-kufs0fxe	9	10	3	3	CD
cord-029882-kufs0fxe	9	11	and	and	CC
cord-029882-kufs0fxe	9	12	that	that	DT
cord-029882-kufs0fxe	9	13	is	be	VBZ
cord-029882-kufs0fxe	9	14	the	the	DT
cord-029882-kufs0fxe	9	15	time	time	NN
cord-029882-kufs0fxe	9	16	when	when	WRB
cord-029882-kufs0fxe	9	17	its	-PRON-	PRP$
cord-029882-kufs0fxe	9	18	effect	effect	NN
cord-029882-kufs0fxe	9	19	is	be	VBZ
cord-029882-kufs0fxe	9	20	supposed	suppose	VBN
cord-029882-kufs0fxe	9	21	to	to	TO
cord-029882-kufs0fxe	9	22	be	be	VB
cord-029882-kufs0fxe	9	23	maximum	maximum	JJ
cord-029882-kufs0fxe	9	24	.	.	.
cord-029882-kufs0fxe	10	1	Administration	Administration	NNP
cord-029882-kufs0fxe	10	2	of	of	IN
cord-029882-kufs0fxe	10	3	HCQ	HCQ	NNP
cord-029882-kufs0fxe	10	4	late	late	RB
cord-029882-kufs0fxe	10	5	in	in	IN
cord-029882-kufs0fxe	10	6	the	the	DT
cord-029882-kufs0fxe	10	7	course	course	NN
cord-029882-kufs0fxe	10	8	of	of	IN
cord-029882-kufs0fxe	10	9	disease	disease	NN
cord-029882-kufs0fxe	10	10	may	may	MD
cord-029882-kufs0fxe	10	11	not	not	RB
cord-029882-kufs0fxe	10	12	be	be	VB
cord-029882-kufs0fxe	10	13	that	that	DT
cord-029882-kufs0fxe	10	14	effective	effective	JJ
cord-029882-kufs0fxe	10	15	.	.	.
cord-029882-kufs0fxe	11	1	Thirdly	thirdly	RB
cord-029882-kufs0fxe	11	2	,	,	,
cord-029882-kufs0fxe	11	3	they	-PRON-	PRP
cord-029882-kufs0fxe	11	4	utilised	utilise	VBD
cord-029882-kufs0fxe	11	5	maximal	maximal	RB
cord-029882-kufs0fxe	11	6	modified	modify	VBD
cord-029882-kufs0fxe	11	7	Sequential	Sequential	NNP
cord-029882-kufs0fxe	11	8	Organ	Organ	NNP
cord-029882-kufs0fxe	11	9	Failure	Failure	NNP
cord-029882-kufs0fxe	11	10	Assessment	Assessment	NNP
cord-029882-kufs0fxe	11	11	(	(	-LRB-
cord-029882-kufs0fxe	11	12	mSOFA	mSOFA	NNP
cord-029882-kufs0fxe	11	13	)	)	-RRB-
cord-029882-kufs0fxe	11	14	scores	score	NNS
cord-029882-kufs0fxe	11	15	for	for	IN
cord-029882-kufs0fxe	11	16	classifying	classify	VBG
cord-029882-kufs0fxe	11	17	patient	patient	JJ
cord-029882-kufs0fxe	11	18	severity	severity	NN
cord-029882-kufs0fxe	11	19	of	of	IN
cord-029882-kufs0fxe	11	20	disease	disease	NN
cord-029882-kufs0fxe	11	21	.	.	.
cord-029882-kufs0fxe	12	1	Recently	recently	RB
cord-029882-kufs0fxe	12	2	it	-PRON-	PRP
cord-029882-kufs0fxe	12	3	been	be	VBN
cord-029882-kufs0fxe	12	4	shown	show	VBN
cord-029882-kufs0fxe	12	5	that	that	IN
cord-029882-kufs0fxe	12	6	this	this	DT
cord-029882-kufs0fxe	12	7	score	score	NN
cord-029882-kufs0fxe	12	8	is	be	VBZ
cord-029882-kufs0fxe	12	9	not	not	RB
cord-029882-kufs0fxe	12	10	accurate	accurate	JJ
cord-029882-kufs0fxe	12	11	for	for	IN
cord-029882-kufs0fxe	12	12	predicting	predict	VBG
cord-029882-kufs0fxe	12	13	severity	severity	NN
cord-029882-kufs0fxe	12	14	of	of	IN
cord-029882-kufs0fxe	12	15	disease	disease	NN
cord-029882-kufs0fxe	12	16	in	in	IN
cord-029882-kufs0fxe	12	17	Covid	Covid	NNP
cord-029882-kufs0fxe	12	18	19	19	CD
cord-029882-kufs0fxe	12	19	patients	patient	NNS
cord-029882-kufs0fxe	12	20	.	.	.
cord-029882-kufs0fxe	13	1	4	4	LS
cord-029882-kufs0fxe	13	2	Fourthly	fourthly	RB
cord-029882-kufs0fxe	13	3	,	,	,
cord-029882-kufs0fxe	13	4	a	a	DT
cord-029882-kufs0fxe	13	5	QTc	QTc	NNP
cord-029882-kufs0fxe	13	6	interval	interval	NN
cord-029882-kufs0fxe	13	7	-	-	HYPH
cord-029882-kufs0fxe	13	8	based	base	VBN
cord-029882-kufs0fxe	13	9	algorithm	algorithm	NN
cord-029882-kufs0fxe	13	10	specifically	specifically	RB
cord-029882-kufs0fxe	13	11	designed	design	VBN
cord-029882-kufs0fxe	13	12	to	to	TO
cord-029882-kufs0fxe	13	13	ensure	ensure	VB
cord-029882-kufs0fxe	13	14	the	the	DT
cord-029882-kufs0fxe	13	15	safe	safe	JJ
cord-029882-kufs0fxe	13	16	use	use	NN
cord-029882-kufs0fxe	13	17	of	of	IN
cord-029882-kufs0fxe	13	18	hydroxychloroquine	hydroxychloroquine	NN
cord-029882-kufs0fxe	13	19	was	be	VBD
cord-029882-kufs0fxe	13	20	utilised	utilise	VBN
cord-029882-kufs0fxe	13	21	.	.	.
cord-029882-kufs0fxe	14	1	This	this	DT
cord-029882-kufs0fxe	14	2	is	be	VBZ
cord-029882-kufs0fxe	14	3	a	a	DT
cord-029882-kufs0fxe	14	4	very	very	RB
cord-029882-kufs0fxe	14	5	safe	safe	JJ
cord-029882-kufs0fxe	14	6	practice	practice	NN
cord-029882-kufs0fxe	14	7	but	but	CC
cord-029882-kufs0fxe	14	8	it	-PRON-	PRP
cord-029882-kufs0fxe	14	9	might	may	MD
cord-029882-kufs0fxe	14	10	have	have	VB
cord-029882-kufs0fxe	14	11	resulted	result	VBN
cord-029882-kufs0fxe	14	12	in	in	IN
cord-029882-kufs0fxe	14	13	exclusion	exclusion	NN
cord-029882-kufs0fxe	14	14	of	of	IN
cord-029882-kufs0fxe	14	15	high	high	JJ
cord-029882-kufs0fxe	14	16	cardiac	cardiac	JJ
cord-029882-kufs0fxe	14	17	risk	risk	NN
cord-029882-kufs0fxe	14	18	patients	patient	NNS
cord-029882-kufs0fxe	14	19	.	.	.
cord-029882-kufs0fxe	15	1	Covid	Covid	NNP
cord-029882-kufs0fxe	15	2	19	19	CD
cord-029882-kufs0fxe	15	3	is	be	VBZ
cord-029882-kufs0fxe	15	4	a	a	DT
cord-029882-kufs0fxe	15	5	multisystem	multisystem	JJ
cord-029882-kufs0fxe	15	6	disease	disease	NN
cord-029882-kufs0fxe	15	7	and	and	CC
cord-029882-kufs0fxe	15	8	the	the	DT
cord-029882-kufs0fxe	15	9	disease	disease	NN
cord-029882-kufs0fxe	15	10	itself	-PRON-	PRP
cord-029882-kufs0fxe	15	11	promotes	promote	VBZ
cord-029882-kufs0fxe	15	12	proarrhythmic	proarrhythmic	JJ
cord-029882-kufs0fxe	15	13	milieu	milieu	NN
cord-029882-kufs0fxe	15	14	with	with	IN
cord-029882-kufs0fxe	15	15	prolonged	prolonged	JJ
cord-029882-kufs0fxe	15	16	QT	qt	NN
cord-029882-kufs0fxe	15	17	intervals	interval	NNS
cord-029882-kufs0fxe	15	18	at	at	IN
cord-029882-kufs0fxe	15	19	baseline	baseline	NN
cord-029882-kufs0fxe	15	20	.5,6	.5,6	.
cord-029882-kufs0fxe	16	1	Risk	risk	NN
cord-029882-kufs0fxe	16	2	assessment	assessment	NN
cord-029882-kufs0fxe	16	3	of	of	IN
cord-029882-kufs0fxe	16	4	HCQ	HCQ	NNP
cord-029882-kufs0fxe	16	5	therapy	therapy	NN
cord-029882-kufs0fxe	16	6	is	be	VBZ
cord-029882-kufs0fxe	16	7	not	not	RB
cord-029882-kufs0fxe	16	8	complete	complete	JJ
cord-029882-kufs0fxe	16	9	if	if	IN
cord-029882-kufs0fxe	16	10	such	such	JJ
cord-029882-kufs0fxe	16	11	patients	patient	NNS
cord-029882-kufs0fxe	16	12	are	be	VBP
cord-029882-kufs0fxe	16	13	excluded	exclude	VBN
cord-029882-kufs0fxe	16	14	.	.	.
cord-029882-kufs0fxe	17	1	Finally	finally	RB
cord-029882-kufs0fxe	17	2	,	,	,
cord-029882-kufs0fxe	17	3	mechanism	mechanism	NN
cord-029882-kufs0fxe	17	4	of	of	IN
cord-029882-kufs0fxe	17	5	action	action	NN
cord-029882-kufs0fxe	17	6	of	of	IN
cord-029882-kufs0fxe	17	7	HCQ	HCQ	NNP
cord-029882-kufs0fxe	17	8	against	against	IN
cord-029882-kufs0fxe	17	9	is	be	VBZ
cord-029882-kufs0fxe	17	10	a	a	DT
cord-029882-kufs0fxe	17	11	part	part	NN
cord-029882-kufs0fxe	17	12	of	of	IN
cord-029882-kufs0fxe	17	13	its	-PRON-	PRP$
cord-029882-kufs0fxe	17	14	broad	broad	JJ
cord-029882-kufs0fxe	17	15	anti	anti	JJ
cord-029882-kufs0fxe	17	16	-	-	JJ
cord-029882-kufs0fxe	17	17	viral	viral	JJ
cord-029882-kufs0fxe	17	18	and	and	CC
cord-029882-kufs0fxe	17	19	immunomodulatory	immunomodulatory	JJ
cord-029882-kufs0fxe	17	20	properties	property	NNS
cord-029882-kufs0fxe	17	21	and	and	CC
cord-029882-kufs0fxe	17	22	no	no	DT
cord-029882-kufs0fxe	17	23	specific	specific	JJ
cord-029882-kufs0fxe	17	24	pharmacologic	pharmacologic	JJ
cord-029882-kufs0fxe	17	25	actions	action	NNS
cord-029882-kufs0fxe	17	26	are	be	VBP
cord-029882-kufs0fxe	17	27	described	describe	VBN
cord-029882-kufs0fxe	17	28	for	for	IN
cord-029882-kufs0fxe	17	29	SARS	SARS	NNP
cord-029882-kufs0fxe	17	30	-	-	HYPH
cord-029882-kufs0fxe	17	31	CoV-2	CoV-2	NNP
cord-029882-kufs0fxe	17	32	infection	infection	NN
cord-029882-kufs0fxe	17	33	.	.	.
cord-029882-kufs0fxe	18	1	7	7	CD
cord-029882-kufs0fxe	18	2	,	,	,
cord-029882-kufs0fxe	18	3	8	8	CD
cord-029882-kufs0fxe	18	4	Majority	majority	NN
cord-029882-kufs0fxe	18	5	of	of	IN
cord-029882-kufs0fxe	18	6	publications	publication	NNS
cord-029882-kufs0fxe	18	7	in	in	IN
cord-029882-kufs0fxe	18	8	the	the	DT
cord-029882-kufs0fxe	18	9	recent	recent	JJ
cord-029882-kufs0fxe	18	10	times	time	NNS
cord-029882-kufs0fxe	18	11	on	on	IN
cord-029882-kufs0fxe	18	12	HCQ	HCQ	NNP
cord-029882-kufs0fxe	18	13	,	,	,
cord-029882-kufs0fxe	18	14	for	for	IN
cord-029882-kufs0fxe	18	15	usage	usage	NN
cord-029882-kufs0fxe	18	16	in	in	IN
cord-029882-kufs0fxe	18	17	Covid	Covid	NNP
cord-029882-kufs0fxe	18	18	19	19	CD
cord-029882-kufs0fxe	18	19	,	,	,
cord-029882-kufs0fxe	18	20	are	be	VBP
cord-029882-kufs0fxe	18	21	limited	limit	VBN
cord-029882-kufs0fxe	18	22	by	by	IN
cord-029882-kufs0fxe	18	23	low	low	JJ
cord-029882-kufs0fxe	18	24	methodical	methodical	JJ
cord-029882-kufs0fxe	18	25	quality	quality	NN
cord-029882-kufs0fxe	18	26	and	and	CC
cord-029882-kufs0fxe	18	27	by	by	IN
cord-029882-kufs0fxe	18	28	and	and	CC
cord-029882-kufs0fxe	18	29	large	large	JJ
cord-029882-kufs0fxe	18	30	have	have	VBP
cord-029882-kufs0fxe	18	31	shown	show	VBN
cord-029882-kufs0fxe	18	32	negative	negative	JJ
cord-029882-kufs0fxe	18	33	or	or	CC
cord-029882-kufs0fxe	18	34	neutral	neutral	JJ
cord-029882-kufs0fxe	18	35	results	result	NNS
cord-029882-kufs0fxe	18	36	.	.	.
cord-029882-kufs0fxe	19	1	9,10	9,10	LS
cord-029882-kufs0fxe	19	2	Weather	Weather	NNP
cord-029882-kufs0fxe	19	3	HCQ	HCQ	NNP
cord-029882-kufs0fxe	19	4	as	as	IN
cord-029882-kufs0fxe	19	5	initial	initial	JJ
cord-029882-kufs0fxe	19	6	anti	anti	JJ
cord-029882-kufs0fxe	19	7	-	-	JJ
cord-029882-kufs0fxe	19	8	viral	viral	JJ
cord-029882-kufs0fxe	19	9	agent	agent	NN
cord-029882-kufs0fxe	19	10	prevents	prevent	VBZ
cord-029882-kufs0fxe	19	11	progression	progression	NN
cord-029882-kufs0fxe	19	12	to	to	IN
cord-029882-kufs0fxe	19	13	severe	severe	JJ
cord-029882-kufs0fxe	19	14	disease	disease	NN
cord-029882-kufs0fxe	19	15	is	be	VBZ
cord-029882-kufs0fxe	19	16	not	not	RB
cord-029882-kufs0fxe	19	17	known	know	VBN
cord-029882-kufs0fxe	19	18	clearly	clearly	RB
cord-029882-kufs0fxe	19	19	.	.	.
cord-029882-kufs0fxe	20	1	In	in	IN
cord-029882-kufs0fxe	20	2	severe	severe	JJ
cord-029882-kufs0fxe	20	3	disease	disease	NN
cord-029882-kufs0fxe	20	4	with	with	IN
cord-029882-kufs0fxe	20	5	multi	multi	JJ
cord-029882-kufs0fxe	20	6	system	system	NN
cord-029882-kufs0fxe	20	7	involvement	involvement	NN
cord-029882-kufs0fxe	20	8	and	and	CC
cord-029882-kufs0fxe	20	9	pro	pro	JJ
cord-029882-kufs0fxe	20	10	arrhythmic	arrhythmic	JJ
cord-029882-kufs0fxe	20	11	milieu	milieu	NN
cord-029882-kufs0fxe	20	12	COVID-19	covid-19	NN
cord-029882-kufs0fxe	20	13	:	:	:
cord-029882-kufs0fxe	20	14	immunopathology	immunopathology	NN
cord-029882-kufs0fxe	20	15	and	and	CC
cord-029882-kufs0fxe	20	16	its	-PRON-	PRP$
cord-029882-kufs0fxe	20	17	implications	implication	NNS
cord-029882-kufs0fxe	20	18	for	for	IN
cord-029882-kufs0fxe	20	19	therapy	therapy	NN
cord-029882-kufs0fxe	20	20	Pharmacologic	Pharmacologic	NNP
cord-029882-kufs0fxe	20	21	treatments	treatment	NNS
cord-029882-kufs0fxe	20	22	for	for	IN
cord-029882-kufs0fxe	20	23	coronavirus	coronavirus	NN
cord-029882-kufs0fxe	20	24	disease	disease	NN
cord-029882-kufs0fxe	20	25	2019	2019	CD
cord-029882-kufs0fxe	20	26	(	(	-LRB-
cord-029882-kufs0fxe	20	27	COVID-19	COVID-19	NNP
cord-029882-kufs0fxe	20	28	)	)	-RRB-
cord-029882-kufs0fxe	20	29	:	:	:
cord-029882-kufs0fxe	20	30	a	a	DT
cord-029882-kufs0fxe	20	31	review	review	NN
cord-029882-kufs0fxe	20	32	Mechanisms	Mechanisms	NNPS
cord-029882-kufs0fxe	20	33	of	of	IN
cord-029882-kufs0fxe	20	34	action	action	NN
cord-029882-kufs0fxe	20	35	of	of	IN
cord-029882-kufs0fxe	20	36	hydroxychloroquine	hydroxychloroquine	NNP
cord-029882-kufs0fxe	20	37	and	and	CC
cord-029882-kufs0fxe	20	38	chloroquine	chloroquine	NN
cord-029882-kufs0fxe	20	39	:	:	:
cord-029882-kufs0fxe	20	40	implications	implication	NNS
cord-029882-kufs0fxe	20	41	for	for	IN
cord-029882-kufs0fxe	20	42	rheumatology	rheumatology	NN
cord-029882-kufs0fxe	20	43	Critically	critically	RB
cord-029882-kufs0fxe	20	44	ill	ill	JJ
cord-029882-kufs0fxe	20	45	SARS	SARS	NNP
cord-029882-kufs0fxe	20	46	-	-	HYPH
cord-029882-kufs0fxe	20	47	CoV2-infected	cov2-infecte	VBN
cord-029882-kufs0fxe	20	48	patients	patient	NNS
cord-029882-kufs0fxe	20	49	are	be	VBP
cord-029882-kufs0fxe	20	50	not	not	RB
cord-029882-kufs0fxe	20	51	stratified	stratify	VBN
cord-029882-kufs0fxe	20	52	as	as	IN
cord-029882-kufs0fxe	20	53	sepsis	sepsis	NN
cord-029882-kufs0fxe	20	54	by	by	IN
cord-029882-kufs0fxe	20	55	the	the	DT
cord-029882-kufs0fxe	20	56	qSOFA	qsofa	JJ
cord-029882-kufs0fxe	20	57	Chloroquine	Chloroquine	NNP
cord-029882-kufs0fxe	20	58	and	and	CC
cord-029882-kufs0fxe	20	59	hydroxychloroquine	hydroxychloroquine	NN
cord-029882-kufs0fxe	20	60	in	in	IN
cord-029882-kufs0fxe	20	61	covid-19	covid-19	NNP
cord-029882-kufs0fxe	20	62	Ventricular	Ventricular	NNP
cord-029882-kufs0fxe	20	63	arrhythmia	arrhythmia	NN
cord-029882-kufs0fxe	20	64	risk	risk	NN
cord-029882-kufs0fxe	20	65	due	due	IN
cord-029882-kufs0fxe	20	66	to	to	IN
cord-029882-kufs0fxe	20	67	chloroquine	chloroquine	NN
cord-029882-kufs0fxe	20	68	/	/	SYM
cord-029882-kufs0fxe	20	69	hydroxychloroquine	hydroxychloroquine	NN
cord-029882-kufs0fxe	20	70	treatment	treatment	NN
cord-029882-kufs0fxe	20	71	for	for	IN
cord-029882-kufs0fxe	20	72	COVID-19	covid-19	NN
cord-029882-kufs0fxe	20	73	:	:	:
cord-029882-kufs0fxe	20	74	Should	Should	MD
cord-029882-kufs0fxe	20	75	it	-PRON-	PRP
cord-029882-kufs0fxe	20	76	be	be	VB
cord-029882-kufs0fxe	20	77	given	give	VBN
cord-029882-kufs0fxe	21	1	In	in	IN
cord-029882-kufs0fxe	21	2	vitro	vitro	FW
cord-029882-kufs0fxe	21	3	antiviral	antiviral	JJ
cord-029882-kufs0fxe	21	4	activity	activity	NN
cord-029882-kufs0fxe	21	5	and	and	CC
cord-029882-kufs0fxe	21	6	projection	projection	NN
cord-029882-kufs0fxe	21	7	of	of	IN
cord-029882-kufs0fxe	21	8	optimized	optimize	VBN
cord-029882-kufs0fxe	21	9	dosing	dosing	NN
cord-029882-kufs0fxe	21	10	design	design	NN
cord-029882-kufs0fxe	21	11	of	of	IN
cord-029882-kufs0fxe	21	12	hydroxychloroquine	hydroxychloroquine	NN
cord-029882-kufs0fxe	21	13	for	for	IN
cord-029882-kufs0fxe	21	14	the	the	DT
cord-029882-kufs0fxe	21	15	treatment	treatment	NN
cord-029882-kufs0fxe	21	16	of	of	IN
cord-029882-kufs0fxe	21	17	severe	severe	JJ
cord-029882-kufs0fxe	21	18	acute	acute	JJ
cord-029882-kufs0fxe	21	19	respiratory	respiratory	JJ
cord-029882-kufs0fxe	21	20	syndrome	syndrome	NN
cord-029882-kufs0fxe	21	21	coronavirus	coronavirus	NN
cord-029882-kufs0fxe	21	22	2	2	CD
cord-029882-kufs0fxe	22	1	(	(	-LRB-
cord-029882-kufs0fxe	22	2	SARS	SARS	NNP
cord-029882-kufs0fxe	22	3	-	-	HYPH
cord-029882-kufs0fxe	22	4	CoV-2	CoV-2	NNP
cord-029882-kufs0fxe	22	5	)	)	-RRB-
cord-029882-kufs0fxe	22	6	Effects	effect	NNS
cord-029882-kufs0fxe	22	7	of	of	IN
cord-029882-kufs0fxe	22	8	chloroquine	chloroquine	NN
cord-029882-kufs0fxe	22	9	on	on	IN
cord-029882-kufs0fxe	22	10	viral	viral	JJ
cord-029882-kufs0fxe	22	11	infections	infection	NNS
cord-029882-kufs0fxe	22	12	:	:	:
cord-029882-kufs0fxe	22	13	an	an	DT
cord-029882-kufs0fxe	22	14	old	old	JJ
cord-029882-kufs0fxe	22	15	drug	drug	NN
cord-029882-kufs0fxe	22	16	against	against	IN
cord-029882-kufs0fxe	22	17	today	today	NN
cord-029882-kufs0fxe	22	18	's	's	POS
cord-029882-kufs0fxe	22	19	diseases	disease	NNS
cord-029882-kufs0fxe	22	20	?	?	.
cord-029882-kufs0fxe	23	1	The	the	DT
cord-029882-kufs0fxe	23	2	Lancet	Lancet	NNP
cord-029882-kufs0fxe	23	3	.	.	.
cord-029882-kufs0fxe	24	1	Infectious	infectious	JJ
cord-029882-kufs0fxe	24	2	Diseases	disease	NNS
cord-029882-kufs0fxe	25	1	The	the	DT
cord-029882-kufs0fxe	25	2	Urgency	Urgency	NNP
cord-029882-kufs0fxe	25	3	of	of	IN
cord-029882-kufs0fxe	25	4	Care	Care	NNP
cord-029882-kufs0fxe	25	5	during	during	IN
cord-029882-kufs0fxe	25	6	the	the	DT
cord-029882-kufs0fxe	25	7	Covid-19	Covid-19	NNP
cord-029882-kufs0fxe	25	8	Pandemic	Pandemic	NNP
cord-029882-kufs0fxe	25	9	-Learning	-Learning	.
cord-029882-kufs0fxe	25	10	as	as	IN
cord-029882-kufs0fxe	25	11	We	-PRON-	PRP
cord-029882-kufs0fxe	25	12	Go	go	VBP
cord-029882-kufs0fxe	25	13	COVID-19	COVID-19	NNP
cord-029882-kufs0fxe	25	14	coronavirus	coronavirus	NN
cord-029882-kufs0fxe	25	15	research	research	NN
cord-029882-kufs0fxe	25	16	has	have	VBZ
cord-029882-kufs0fxe	25	17	overall	overall	RB
cord-029882-kufs0fxe	25	18	low	low	JJ
cord-029882-kufs0fxe	25	19	methodological	methodological	JJ
cord-029882-kufs0fxe	25	20	quality	quality	NN
cord-029882-kufs0fxe	25	21	thus	thus	RB
cord-029882-kufs0fxe	25	22	far	far	RB
cord-029882-kufs0fxe	25	23	:	:	:
cord-029882-kufs0fxe	25	24	case	case	NN
cord-029882-kufs0fxe	25	25	in	in	IN
cord-029882-kufs0fxe	25	26	point	point	NN
cord-029882-kufs0fxe	25	27	for	for	IN
cord-029882-kufs0fxe	25	28	chloroquine	chloroquine	NN
cord-029882-kufs0fxe	25	29	/	/	SYM
cord-029882-kufs0fxe	25	30	hydroxychloroquine	hydroxychloroquine	NNP